CHF 134.00

Development of Novel Stability Indicating Methods Using Liquid Chromatography

Inglese · Tascabile

Spedizione di solito entro 1 a 2 settimane

Descrizione

Ulteriori informazioni


Reversed-phase high-performance liquid chromatography (RP-HPLC) has become the most widely used method for pharmaceutical analysis, as it ensures accuracy, specificity and reproducibility for the quantification of drugs, while avoiding interference from any of the excipients that are normally present in pharmaceutical dosage forms.
This book presents a simple methodology for developing stability-indicating methods and offers a 'how-to guide' to creating novel stability-indicating methods using liquid chromatography. It provides the detailed information needed to devise a stability-indicating method for drug substances and drug products that comply with international regulatory guidelines. As such, it is a must-read for anyone engaged in analytical and bioanalytical chemistry: professionals at reference, test, and control laboratories; students and academics at research laboratories, and scientists working for chemical, pharmaceutical, and biotechnology companies.  

Info autore










Dr. Mukesh Maithani, M.Pharma., Ph.D. in pharmaceutical sciences is a Scientist working with the Multidisciplinary Research Unit (ICMR), University Center of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, India. He received the Young Scientist Award from the All India Medicos Society during its 26th
 National Medical Congress in 2011 and has more than 12 years experience as a Research Scientist at Zydus Research Centre, Ahmadabad; and as a Senior Research Scientist at the Analytical Development Laboratory, Alembic Research Centre, Vadodara.
Dr. Maithani has made major contributions to pharmaceutical analysis, herbal formulations, and the standardization of drugs. His expertise includes drug discovery, novel analytical techniques, herbal excipients and drugs, targeted drug delivery etc. He has published more than thirty papers in national and international journals and conference proceedings, and is a co-author of seventeen books/book chapters. In addition, Dr. Maithani serves as a reviewer and advisory board member for several international and national journals.

Dr. Parveen Bansal, Ph.D. (Biochemistry), FRSM, FICA (USA), Joint Director, Baba Farid University of Health Sciences, has more than 23 years experience in various positions including Assistant Director/Founder Head of the National Institute of Ayurvedic Pharmaceutical Research. He represented India as a member of the 23rd
 Indian Scientific Expedition to Antarctica. He holds three Young Scientist Awards, a Gold Medal from Gujarat Ayurveda University, Jamnagar, an Honorary Fellowship from the International Council of Ayurveda (USA), and a WHO In-country Fellowship from the World Health Organization. He has been nominated as a Member of the Screening Committee for the Cancer Consortium R&D Program, Department of Biotechnology, GOI, has published more than 170 research papers, 17 books and 46 book chapters, and serves as a reviewer or editorial board member for 35 high-impact international journals.


Dettagli sul prodotto

Autori Mukes Maithani, Mukesh Maithani, Parveen Bansal
Editore Springer, Berlin
 
Contenuto Libro
Forma del prodotto Tascabile
Data pubblicazione 01.08.2020
Categoria Scienze naturali, medicina, informatica, tecnica > Medicina > Branche cliniche
 
EAN 9789811387258
ISBN 978-981-1387-25-8
Numero di pagine 101
Illustrazioni XXII, 101 p. 36 illus., 7 illus. in color.
Dimensioni (della confezione) 15.6 x 0.7 x 23.5 cm
 

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.